These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 11118047

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
    Li AM, Zhang CX, Fu XP, Zhang ZW, Xue QH, Yan RM, Yi LH.
    Chin Med J (Engl); 2005 May 20; 118(10):824-7. PubMed ID: 15989762
    [Abstract] [Full Text] [Related]

  • 5. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver--magnetic nanoparticles in cancer treatment.
    Krukemeyer MG, Krenn V, Jakobs M, Wagner W.
    J Surg Res; 2012 Jun 01; 175(1):35-43. PubMed ID: 21470623
    [Abstract] [Full Text] [Related]

  • 6. Real-time cell analysis of human cancer cell lines after chemotherapy with functionalized magnetic nanoparticles.
    Dürr S, Lyer S, Mann J, Janko C, Tietze R, Schreiber E, Herrmann M, Alexiou C.
    Anticancer Res; 2012 May 01; 32(5):1983-9. PubMed ID: 22593476
    [Abstract] [Full Text] [Related]

  • 7. Visualisation of tumour regression after local chemotherapy with magnetic nanoparticles - a pilot study.
    Lyer S, Tietze R, Jurgons R, Struffert T, Engelhorn T, Schreiber E, Dörfler A, Alexiou C.
    Anticancer Res; 2010 May 01; 30(5):1553-7. PubMed ID: 20592340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical applications of magnetic drug targeting.
    Lübbe AS, Alexiou C, Bergemann C.
    J Surg Res; 2001 Feb 01; 95(2):200-6. PubMed ID: 11162046
    [Abstract] [Full Text] [Related]

  • 12. [Magnetic carrier method- an expectation for antitumoral therapy].
    Iacob G, Ciochină AD, Bredeţean O.
    Rev Med Chir Soc Med Nat Iasi; 2001 Feb 01; 105(4):815-21. PubMed ID: 12092246
    [Abstract] [Full Text] [Related]

  • 13. [Targeting technology utilizing magnetic microparticulate system for cancer therapy].
    Morimoto Y, Natsume H.
    Nihon Rinsho; 1998 Mar 01; 56(3):649-56. PubMed ID: 9549351
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iron oxide nanoparticles for sustained delivery of anticancer agents.
    Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V.
    Mol Pharm; 2005 Mar 01; 2(3):194-205. PubMed ID: 15934780
    [Abstract] [Full Text] [Related]

  • 17. Quantification of magnetic nanoparticles by magnetorelaxometry and comparison to histology after magnetic drug targeting.
    Wiekhorst F, Seliger C, Jurgons R, Steinhoff U, Eberbeck D, Trahms L, Alexiou C.
    J Nanosci Nanotechnol; 2006 Mar 01; 6(9-10):3222-5. PubMed ID: 17048540
    [Abstract] [Full Text] [Related]

  • 18. [Magnetic drug targeting. New paths for the local concentration of drugs for head and neck cancer].
    Simon C.
    HNO; 2005 Jul 01; 53(7):600-1. PubMed ID: 15868128
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.